Diabetic Macular Oedema
Diabetic Macular Oedema (DMO) is a complication of diabetes that occurs when fluid leaks into the macula, the part of the retina responsible for sharp vision, leading to swelling and vision impairment.
We are investigating a new treatment using a dexamethasone implant for patients with diabetic macular edema. The goal is to see if it improves vision and how well patients tolerate the treatment.
Health conditions and diseases that the clinical trial is designed to study and treat.
Diabetic Macular Oedema (DMO) is a complication of diabetes that occurs when fluid leaks into the macula, the part of the retina responsible for sharp vision, leading to swelling and vision impairment.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.